A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) A61K 31/70 (2006.01) A61K 39/12 (2006.01) A61K 39/145 (2006.01) A61K 39/155 (2006.01) A61K 39/17 (2006.01) A61K 39/21 (2006.01) A61K 39/215 (2006.01) A61K 39/245 (2006.01) A61K 39/255 (2006.01) A61K 39/295 (2006.01) C07K 14/01 (2006.01) C07K 14/03 (2006.01) C07K 14/055 (2006.01) C07K 14/08 (2006.01) C07K 14/11 (2006.01) C07K 14/115 (2006.01) C07K 14/125 (2006.01) C07K 14/15 (2006.01) C07K 14/165 (2006.01)
Patent
CA 2261343
An avian vaccine formula including at least three polynucleotide vaccine valencies that each include a plasmid containing an avian pathogen valency gene capable of being expressed in vivo in host cells. Said valencies are selected from the group which consists of Marek's disease virus, Newcastle disease virus, infectious bursal disease virus, infectious bronchitis virus and infectious anaemia virus. The plasmids include one or more genes per valency, and said genes are selected from the group which consists of gB and gD for Marek's disease virus, HN and F for Newcastle disease virus, VP2 for infectious bursal disease virus, S, M and N for infectious bronchitis virus and C + NS1 for infectious anaemia virus.
La formule de vaccin aviaire, comprend au moins trois valences de vaccin polynucléotidique comprenant chacune un plasmide intégrant, de manière à l'exprimer in vivo dans les cellules hôtes, un gène d'une valence de pathogène aviaire, ces valences étant choisies parmi le groupe consistant en virus de la maladie de Marek, virus de la maladie de Newcastle, virus de la maladie de Gumboro, virus de la bronchite infectieuse, virus de l'anémie infectieuse, les plasmides comprenant, pour chaque valence, un ou plusieurs des gènes choisis parmi le groupe consistant en gB et gD pour le virus de la maladie de Marek, MN et F pour le virus de la maladie de Newcastle, VP2 pour le virus de la maladie de Gumboro, S, M et N pour le virus de la bronchite infectieuse, C + NS1 pour le virus de l'anémie infectieuse.
Audonnet Jean-Christophe
Bouchardon Annabelle
Riviere Michel
Fetherstonhaugh & Co.
Merial
LandOfFree
Avian polynucleotide vaccine formula does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Avian polynucleotide vaccine formula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Avian polynucleotide vaccine formula will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1545502